CG Oncology Income Statement (2023-2026) | CGON

Income Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter) 3.86M4.04M5.07M4.33M47.06M66.66M67.54M62.50M76.22M76.23M78.28M80.69M88.01M88.64M
Revenue & cost
Revenue (Quarter) 0.19M0.01M0.00M0.53M0.11M0.04M0.46M0.05M1.67M2.32M1.08M1.16M
Gross Profit (Quarter) 0.04M0.46M0.05M0.09M-0.75M-1.88M-2.77M
Operating items
Research & Development (Quarter) 7.84M9.83M11.73M16.34M17.21M18.47M19.62M26.80M27.47M31.33M27.88M29.96M43.73M54.66M
Selling, General & Administrative (Quarter) 2.07M2.49M2.32M3.02M5.79M7.49M8.72M11.71M14.79M17.41M23.33M17.99M20.78M28.98M
Other Operating Expenses (Quarter) 1.58M3.07M2.96M3.92M
Operating Expenses (Quarter) 9.91M12.33M14.05M19.36M23.00M25.96M28.34M38.51M42.26M48.74M52.80M51.02M67.47M87.56M
Operating Income (Quarter) -9.72M-12.33M-14.04M-19.36M-22.47M-25.85M-28.30M-38.05M-42.20M-48.74M-51.13M-48.70M-66.39M-86.40M
EBIT (Quarter) -9.72M-12.33M-14.04M-19.36M-22.47M-25.85M-28.30M-38.05M-42.20M-48.74M-51.13M-48.70M-66.39M-86.40M
Non-operating items
Interest & Investment Income (Quarter) 1.05M0.77M2.28M2.80M5.54M6.94M7.89M6.25M7.75M7.32M7.42M7.44M6.29M7.33M
Other Non Operating Income (Quarter) 0.01M-0.06M-0.01M-0.00M-0.01M0.01M-0.00M0.01M0.01M-0.00M-0.10M-0.05M-0.10M0.02M
Non Operating Income (Quarter) 1.05M0.71M2.27M2.80M5.54M6.95M7.89M6.25M7.75M7.32M7.32M7.39M6.19M7.34M
Net income details
EBT (Quarter) -8.95M-11.60M-11.82M-16.55M-248.12M-171.94M-177.59M-31.86M-121.77M-148.18M-234.43M-40.98M-442.99M-465.70M
Profit After Tax (Quarter) -8.67M-11.61M-11.77M-16.55M-16.93M-18.90M-20.41M-31.80M-34.45M-41.43M-43.81M-41.31M-60.20M-79.10M
Income from Continuing Operations (Quarter) -8.95M-11.60M-11.82M-16.55M-248.12M-171.94M-177.59M-31.86M-121.77M-148.18M-234.43M-40.98M-442.99M-465.70M
Consolidated Net Income (Quarter) -8.95M-11.60M-11.82M-16.55M-248.12M-171.94M-177.59M-31.86M-121.77M-148.18M-234.43M-40.98M-442.99M-465.70M
Income towards Parent Company (Quarter) -8.95M-11.60M-11.82M-16.55M-248.12M-171.94M-177.59M-31.86M-121.77M-148.18M-234.43M-40.98M-442.99M-465.70M
Preferred Dividend Payments (Quarter) 3.73M3.78M0.41M5.93M
Net Income towards Common Stockholders (Quarter) -12.40M-15.39M-17.51M-22.49M-16.93M-18.90M-20.41M-31.80M-121.77M-148.18M-234.43M-40.98M-442.99M-465.70M
Additional items
EPS (Basic) (Quarter) -3.22-3.93-4.00-5.19-0.36-0.28-0.30-0.51-1.60-1.94-3.06-0.53-5.24-5.28
EPS (Diluted) (Quarter) -3.22-3.93-4.00-5.19-0.36-0.28-0.30-0.51-1.60-1.94-3.06-0.53-5.24-5.28
Shares Outstanding (Quarter) 3.86M3.92M4.38M4.33M47.06M66.65M67.14M62.50M76.19M76.23M76.73M77.30M84.52M88.20M
Shares Outstanding (Diluted) (Quarter) 3.86M3.92M4.38M4.33M47.06M66.65M67.14M62.50M76.19M76.23M76.73M77.30M84.52M88.20M
EBITDA (Quarter) -9.72M-12.33M-14.04M-19.36M-22.47M-25.85M-28.30M-38.05M-42.20M-48.74M-51.13M-48.70M-66.39M-86.40M
Interest Expenses (Quarter) 0.27M0.04M0.06M231.19M153.03M157.18M0.06M87.31M106.75M190.73M-0.28M382.89M386.63M